$4.11
-0.20-4.65%
Last update: Nov 4, 12:46 PM
Kyntra Bio Inc
KYNBNASDAQ
The average analyst price target for Kyntra Bio is $36.80, 795.5% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $30 to $43. The latest change came on Oct 13, 2026, when Maxim Group initiated coverage of Kyntra Bio with a Buy rating and a $35 price target.
Price Target Range — 3 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
